Industry Partners
Sponsor IMARI
Be at the center of scientific innovation & industry collaboration.
ASM and the Infectious Diseases Society of America (IDSA) are excited to host for the second year, the Interdisciplinary Meeting on Antimicrobial Resistance and Innovation (IMARI) — an unprecedented conference that brings together the brightest minds across science, medicine, and industry to address one of the most urgent global health threats of our time: antimicrobial resistance (AMR).
Held in Las Vegas, NV, from January 27–29, 2027, this meeting delivers a powerful and collaborative space and is expected to gather nearly 600 researchers, clinicians, industry stakeholders, investors, regulators, and policymakers to engage in meaningful dialogue and accelerate innovation.
IMARI is more than a conference — it’s a catalyst for global change in how we collaborate to discover, develop, deploy, and regulate antimicrobials. As a sponsor, your organization will play a visible, strategic role in shaping the future of infectious disease treatment and innovation.
Benefits of Sponsorship
- Exclusive Exposure to leading academic and clinical researchers, pharmaceutical executives, and government agencies
- Strategic Positioning as a leader in antimicrobial discovery and development
- Networking Access to future collaborators, clients, and funding partners
- Brand Visibility on-site and digitally
- Speaking and Thought Leadership Opportunities (at select levels)
Who Attends
- Drug discovery and translational scientists
- Clinical researchers and infectious disease specialists
- Pharmaceutical, diagnostics and biotech executives
- Regulatory and government agency representatives
- Health economists, policy advocates, and NGO leaders
- Investors and funders focused on global health innovation